SCHEMBL19960205

SCHEMBL19960205

O=P(c1ccccc1)(c1ccc2ccccc2c1)c1cccc2c3nc4ccccc4cc3c3nc4ccccc4n3c12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.36
KDM4E B2RXH2 5/20 0.36
POLB P06746 3/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
HSD17B10 Q99714 1/20 0.36
ALDH1A1 P00352 6/20 0.36
HPGD P15428 5/20 0.36
KMT2A Q03164 6/20 0.34
MEN1 O00255 4/20 0.34
CAMKK1 Q8N5S9 2/20 0.34
CAMKK2 Q96RR4 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CASP1 P29466 1/20 0.34
CYP2C19 P33261 1/20 0.34
CASP7 P55210 1/20 0.34
TOP1 P11387 1/20 0.33
SMN1; SMN2 Q16637 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19960120 0.94 KDM4E (0.40) MAPTKDM4EPOLBLMNATP53
SCHEMBL19960162 0.90 KDM4E (0.39) MAPTKDM4EPOLBLMNATP53
SCHEMBL19960172 0.85 KMT2A (0.43) MAPTKDM4EPOLBLMNATP53
SCHEMBL19960111 0.84 KDM4E (0.43) MAPTKDM4EPOLBLMNATP53
SCHEMBL19960207 0.84 MAPT (0.36) MAPTKDM4EPOLBLMNATP53
SCHEMBL19959795 0.83 KDM4E (0.35) MAPTKDM4EPOLBLMNATP53
SCHEMBL19960130 0.83 KMT2A (0.36) MAPTKDM4EPOLBLMNATP53
SCHEMBL20090152 0.82 ALDH1A1 (0.38) MAPTKDM4EPOLBLMNATP53
SCHEMBL19965989 0.82 KDM4E (0.41) MAPTKDM4EPOLBLMNATP53
SCHEMBL19960147 0.82 KMT2A (0.39) MAPTKDM4EPOLBLMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2020-06-30 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 MAPT 1310/4885KDM4E 1997/4885POLB 2517/4885
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 MAPT 1310/4885KDM4E 1997/4885POLB 2517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.